Jonathan Rubin - SVP, Chief Medical Officer at SUPERNUS PHARMACEUTICALS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Chief Medical Officer
Issuer Symbol
SUPN on Nasdaq
All Insider Reports
All Insider Reports

Jonathan Rubin - trading volume in the past year for SUPERNUS PHARMACEUTICALS, INC.

Holdings reported by Jonathan Rubin for SUPERNUS PHARMACEUTICALS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 11,015 $509,003 $46.21 25 Sep 2025 Direct
Restricted Stock Unit 2,500 $97,875 $39.15 23 Feb 2025 Direct Common Stock
Performance Share Unit 0 $0 $35.59 25 Sep 2025 Direct Common Stock
Performance Share Units 0 $0 $39.15 21 Feb 2025 Direct Common Stock
Employee Stock Option (Right to Buy) 20,000 19 Feb 2025 Direct Common Stock

Transactions reported by Jonathan Rubin for SUPERNUS PHARMACEUTICALS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.